- Cello Group expects results for the year ended 31 Dec to be in line with forecasts.

The group said it traded well in 2017, with continued strong overall and like-for-like growth from Cello Health.

The group also said it had successfully integrated two US acquisitions into Cello Health.

At 9:27am: [LON:CLL] Cello Group PLC share price was +0.5p at 126p

Story provided by